Skip to Main Content

Paper Details

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
Oncoimmunology
199
2018
Breast Cancer, Cancer, FID, Luminal A tumor, Luminal A tumor subtype, PID, TMB, TMB-Hi tumors, Tumor immune subclasses, WID, breast cancer, breast cancers, chromosome 1q immune-regulatory genes, immune-infiltrate dispositions, patients, prognostic immune subclasses, tumor, tumors
Author NameAffiliation
Ashok K PullikuthWake Forest School of Medicine
Jeff W ChouWake Forest Comprehensive Cancer Center
Jeff W ChouWake Forest School of Medicine
Katherine A HoadleyUniversity of North Carolina at Chapel Hill
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Katherine A HoadleyUniversity of North Carolina at Chapel Hill
Katherine A HoadleyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Sandra DemariaWeill Cornell Medical College
Davide BedognettiSidra Medical and Research Center
Wendell D Jones
Wendell D Jones
Michael L GatzaRutgers Cancer Institute of New Jersey
Charles M PerouUniversity of North Carolina at Chapel Hill
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Lance D MillerWake Forest Comprehensive Cancer Center
Lance D MillerWake Forest School of Medicine
  • 1 - 16

Datasets

Release 1.2